Critical Care

official impact factor 4.60
Search for
Advanced search
Critical Care
Tools
Open Access Highly Access Research

Filter survival time and requirement of blood products in patients with severe sepsis receiving drotrecogin alfa (activated) and requiring renal replacement therapy

Luigi Camporota, Eleonora Corno, Eleonora Menaldo, John Smith, Katie Lei, Richard Beale and Duncan Wyncoll*

Author Affiliations

Adult Intensive Care Unit, Guy's and St Thomas' NHS Foundation Trust, St Thomas' Hospital, 1st Floor East Wing, Lambeth Palace Road. London SE1 7EH, UK

For all author emails, please log on.

Critical Care 2008, 12:R163 doi:10.1186/cc7163

Published: 18 December 2008

Additional files

Additional file 1:

Word file containing a listing of indications and contraindications to the use of Drotrecogin alfa (activated).

Format: DOC Size: 29KB Download file

This file can be viewed with: Microsoft Word Viewer

Open Data